Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Alendronate for use in the treatment of osteoporosis
No-Receipt date
2007-01280 - 26/03/2007
No-Filing date
20070400961 - 29/03/2007
No-Granting date
3061353 - 30/03/2007
No-EPO application date
01201913.9 - 17/07/1998
No-EPO granting date
1175904 - 28/03/2007
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
3/2007 - 25/04/2007
Expiration date
18/07/2018
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US53351 P22/07/1997/US
US53535 P23/07/1997/US
GB971759020/08/1997/GB
GB971785022/08/1997/GB
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 19/10
A61K 31/663
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20070800040
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
326154
MERCK SHARP & DOHME CORP.
P.O. BOX 2000
RAHWAY NEW JERSEY 07065-0900
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
488931
DAIFOTIS, ANASTASIA G.
488932
SANTORA, ARTHUR C., II
488933
YATES, JOHN A.
Representatives
Code
Firstname
Surname
Address
Town
Zip
742
KONSTANTINOS
KILIMIRIS
XATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2119
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
14/06/2010
Αλλαγή Επωνυμίας Δικαιούχου (7e801)
ΑΡ. ΠΡΩΤ. 1901/31/3/2010, ΚΩΔ. ΠΛΗΡ. 742
207265 Merck & Co. Inc. P.O. Box 2000 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Rahway New Jersey 07065-0900
326154 Merck Sharp & Dohme Corp. P.O. Box 2000 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Rahway New Jersey 07065-0900
Title Instruments
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).